Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Effect of Palm and LI4 (Hegu) Acupressure on Labor Pain, Labor Duration and Satisfaction

9 de noviembre de 2026 actualizado por: Emine Tekeli

The Effect of Palm and LI4 Acupressure Applications During Labor on Labor Pain, Duration and Satisfaction: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effects of palm (hand point) pressure and LI4 (Hegu) acupressure applied during labor on labor pain, duration of labor, and maternal birth satisfaction. A total of 105 nulliparous women aged 18-35 years with a term, low-risk, singleton pregnancy in spontaneous labor will be randomly assigned to three groups of 35: a palm pressure group, an LI4 acupressure group, and a control group receiving routine labor care. In the palm group, women press a wooden comb into their own palm during contractions. In the LI4 group, the researcher applies pressure to the LI4 point during contractions using an Electronic Acupuncture Pen and Meridian Massage Device. Applications are performed during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm. Pain is measured with a Visual Analog Scale and an observer-rated pain expression scale (ESVADOPA) before and 30 minutes after each application. Duration of labor and neonatal Apgar scores are recorded, and birth satisfaction is assessed within 4 hours after birth. The study is conducted in a single center in Gaziantep, Türkiye.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Estimado)

105

Fase

  • No aplica

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 35 años (Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Femenino

Descripción

Inclusion Criteria:

  • Aged 18-35 years
  • Able to read, write and understand Turkish
  • Nulliparous woman with a term pregnancy (37-42 weeks of gestation)
  • Singleton, live fetus in vertex presentation
  • Spontaneous onset of labor
  • Cervical dilatation of 4 cm or more
  • Estimated fetal weight of 2500-4000 g confirmed by ultrasound by a physician
  • No risk factors in obstetric and medical history (low-risk pregnancy)
  • Willing to participate and gives written informed consent

Exclusion Criteria:

  • Multiple pregnancy
  • Pregnancy achieved by in vitro fertilization (IVF)
  • Complicated pregnancy (e.g., gestational diabetes, hypertensive disorders)
  • Previous cesarean delivery
  • Presentation anomaly
  • Induction of labor
  • Neurological, psychiatric or communication-impairing disease
  • Use of, or planned use of, another pain-relief method (e.g., hot/cold application, TENS, aromatherapy, massage)
  • Structural or chromosomal fetal anomaly
  • Obesity according to the World Health Organization classification (BMI 30 kg/m2 or higher)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Palm Pressure Group

Women apply pressure with a curved wooden comb to their own palm (Lao Gong point) during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, under the supervision of the researcher. Routine labor care continues.

Palm Pressure Group:

A curved wooden comb is pressed by the woman into her own palm (Lao Gong point) during contractions. After the researcher demonstrates the technique, pressure is applied for six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, with pauses during the rest phases between contractions.

Otros nombres:
  • Hand point comb
  • LI4 pressure
Experimental: LI4 Acupressure Group

The researcher locates the LI4 (Hegu) point with an Electronic Acupuncture Pen and Meridian Massage Device and applies pressure (about 3-5 kg of force) during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm. Routine labor care continues.

The researcher locates the LI4 (Hegu) point on the back of the hand with an Electronic Acupuncture Pen and Meridian Massage Device, which signals the point by light and sound. Pressure (about 3-5 kg of force) is then applied with the device. The application is performed during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, with pauses during the rest phases between contractions.

Sin intervención: Control Group

Women receive routine midwifery care in the delivery room with no additional intervention. Pain measurements are made at the same dilatation stages as in the other groups.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Labor pain intensity measured by Visual Analog Scale (VAS)
Periodo de tiempo: Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor

Women rate the pain felt after a contraction on a vertical Visual Analog Scale from 0 (no pain) to 10 (severe pain). The mark is measured with a ruler and recorded as the pain score. Higher scores indicate more pain.

Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Pain expression measured by the Rating Scale of Pain Expression during Childbirth (ESVADOPA)
Periodo de tiempo: Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor

An independent observer who is unaware of group allocation rates pain expression during contractions with ESVADOPA. The scale has 6 items (facial muscles, body response, verbal response, restlessness, ability to relax, vegetative symptoms), each scored 0-3. Total scores range from 0 to 18; higher scores indicate more pain expression.

Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor
Duration of labor
Periodo de tiempo: From admission to the delivery room until delivery of the placenta (during labor and birth)

Duration of labor stages calculated in minutes from times recorded on the labor follow-up form: admission to the delivery room, start and end of the second stage, and delivery of the placenta.

From admission to the delivery room until delivery of the placenta (during labor and birth)
Birth satisfaction measured by the Birth Satisfaction Scale
Periodo de tiempo: Within 4 hours after birth

Women complete the 10-item Birth Satisfaction Scale (Turkish version), rated on a 5-point Likert scale (0-4), with reverse scoring for 4 items. Total scores range from 0 to 40; higher scores indicate greater birth satisfaction.

Within 4 hours after birth
Neonatal Apgar score
Periodo de tiempo: 1 minute and 5 minutes after birth

Apgar scores of the newborn, recorded on the labor follow-up form. Scores range from 0 to 10; higher scores indicate a better condition of the newborn.

1 minute and 5 minutes after birth

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

13 de noviembre de 2026

Finalización primaria (Estimado)

28 de febrero de 2027

Finalización del estudio (Estimado)

30 de marzo de 2027

Fechas de registro del estudio

Enviado por primera vez

9 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

9 de noviembre de 2026

Publicado por primera vez (Actual)

16 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

16 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

9 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2026/64

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir